New publications from WHO GMP

Safety review of 8-aminoquinoline antimalarial medicines

Written by external authors, this document reviews published and unpublished studies about the safety of primaquine and its precursors, with particular attention to haemolytic anaemia in G6PD-deficient individuals. The study was prepared for and discussed at a 2012 meeting of the WHO evidence review group on the safety and effectiveness of single-dose primaquine as a P. falciparum gametocytocide.

Elimination scenario planning

WHO has published a manual to help malaria-endemic countries to assess the feasibility of moving towards elimination. The new guide provides a comprehensive framework to assess different scenarios and timelines for reducing the disease burden and moving towards elimination, depending on programme coverage and funding availability.